BioRestorative Therapies, Inc. (BRTX)
2.14
-0.13
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
2.25
+0.11
(+5.14%)
After-Hours: 20:00
BioRestorative Therapies Net Income (Quarterly) : -2.154M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.154M |
| December 31, 2025 | -3.208M |
| September 30, 2025 | -3.038M |
| June 30, 2025 | -2.656M |
| March 31, 2025 | -5.340M |
| December 31, 2024 | -1.636M |
| September 30, 2024 | -1.091M |
| June 30, 2024 | -4.029M |
| March 31, 2024 | -2.223M |
| December 31, 2023 | 1.173M |
| September 30, 2023 | 4.768M |
| June 30, 2023 | -5.709M |
| March 31, 2023 | -7.173M |
| December 31, 2022 | -4.348M |
| September 30, 2022 | -4.656M |
| June 30, 2022 | -4.675M |
| March 31, 2022 | -4.816M |
| December 31, 2021 | -20.40M |
| September 30, 2021 | -4.184M |
| June 30, 2021 | -4.063M |
| March 31, 2021 | -15.65M |
| December 31, 2020 | -5.761M |
| September 30, 2020 | -0.8363M |
| June 30, 2020 | 2.876M |
| March 31, 2020 | -7.551M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.551M |
| September 30, 2019 | -5.057M |
| June 30, 2019 | -4.157M |
| March 31, 2019 | -3.883M |
| December 31, 2018 | -3.570M |
| September 30, 2018 | -2.925M |
| June 30, 2018 | -3.514M |
| March 31, 2018 | -2.508M |
| December 31, 2017 | -1.860M |
| September 30, 2017 | -2.052M |
| June 30, 2017 | -2.747M |
| March 31, 2017 | -2.786M |
| December 31, 2016 | -2.057M |
| September 30, 2016 | -1.834M |
| June 30, 2016 | -2.258M |
| March 31, 2016 | -2.487M |
| December 31, 2015 | -3.119M |
| September 30, 2015 | -1.624M |
| June 30, 2015 | -1.420M |
| March 31, 2015 | -1.760M |
| December 31, 2014 | -1.484M |
| September 30, 2014 | -1.100M |
| June 30, 2014 | -1.333M |
| March 31, 2014 | -1.670M |
| December 31, 2013 | -1.631M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -43.20M |
| CareDx, Inc. | 110.64M |
| Natera, Inc. | -66.97M |
| Exagen, Inc. | -3.196M |
| Sera Prognostics, Inc. | -9.139M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0232M |
| Total Expenses (Quarterly) | 2.178M |
| EPS Diluted (Quarterly) | -2.431 |
| Enterprise Value | -0.8314M |
| Gross Profit Margin (Quarterly) | -157.8% |
| Profit Margin (Quarterly) | -9.29K% |
| Earnings Yield | -1.05K% |
| Normalized Earnings Yield | -1220.71 |